Cette étude menée par une équipe du Regenstrief Institute (Indianapolis) et publiée dans le Lancet apporte de nouvelles ...

RIYAD, Arabie saoudite, 18 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSHRC) ...

Cette équipe de l'Université du Massachusetts à Amherst vient de découvrir une nouvelle méthode pour lutter contre la prise de poids après la quarantaine : une séance quotidienne de sauna améliore la ...

RIYADH, Saudi Arabia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is ...

L’inclusion scolaire des élèves en situation de handicap représente un challenge pour tous les acteurs : enfants, famille, ...

Shareholders are encouraged to listen to the fireside chat hosted on October 15, 2024 at 4:30 p.m. ET by the management teams of Better Choice and SRx Health, which can be accessed by visiting https:/ ...

DURHAM, Caroline du Nord, 18 oct. 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE), l’un des principaux organismes internationaux de recherche sous contrat (CRO), a annoncé aujourd’hui la publication ...

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces ...

Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, ...

Richland WA N, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Certifies new clinic for IsoPet therapy.

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible f ...

ZORYVE cream, 0.15%, is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 6 years of age and older. ZORYVE foam, 0.3%, is indicated for the ...